AI assistant
HERBALIFE LTD. — Director's Dealing 2018
Mar 1, 2018
32337_dirs_2018-03-01_40e21185-d867-4899-ae36-3167331f3750.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2018-02-27
Reporting Person: Hienrich Edi (SVP/Managing Director EMEA)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-28 | Common Stock | M | 15133 | $79.58 | Acquired | 45060 | Direct |
| 2018-02-28 | Common Stock | D | 13077 | $92.10 | Disposed | 31983 | Direct |
| 2018-02-28 | Common Stock | F | 1124 | $92.10 | Disposed | 30859 | Direct |
| 2018-02-28 | Common Stock | M | 3359 | $62.51 | Acquired | 34218 | Direct |
| 2018-02-28 | Common Stock | D | 2280 | $92.10 | Disposed | 31938 | Direct |
| 2018-02-28 | Common Stock | F | 590 | $92.10 | Disposed | 31348 | Direct |
| 2018-03-01 | Common Stock | S | 15104 | $91.61 | Disposed | 16244 | Direct |
| 2018-03-01 | Common Stock | S | 8900 | $92.32 | Disposed | 7344 | Direct |
| 2018-03-01 | Common Stock | S | 100 | $93.06 | Disposed | 7244 | Direct |
| 2018-02-27 | Common Stock | M | 2936 | $30.44 | Acquired | 8365 | Indirect |
| 2018-02-27 | Common Stock | D | 1032 | $92.10 | Disposed | 7333 | Indirect |
| 2018-02-27 | Common Stock | F | 958 | $92.10 | Disposed | 6375 | Indirect |
| 2018-02-28 | Common Stock | M | 2723 | $79.58 | Acquired | 9098 | Indirect |
| 2018-02-28 | Common Stock | D | 2353 | $92.10 | Disposed | 6745 | Indirect |
| 2018-02-28 | Common Stock | F | 187 | $92.10 | Disposed | 6558 | Indirect |
| 2018-02-28 | Common Stock | M | 655 | $62.51 | Acquired | 7213 | Indirect |
| 2018-02-28 | Common Stock | D | 445 | $92.10 | Disposed | 6768 | Indirect |
| 2018-02-28 | Common Stock | F | 106 | $92.10 | Disposed | 6662 | Indirect |
| 2018-03-01 | Common Stock | S | 4985 | $92.08 | Disposed | 1677 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-28 | Stock Appreciation Rights | $79.58 | M | 15133 | Disposed | 2023-12-19 | Common Stock (15133) | Direct |
| 2018-02-28 | Stock Appreciation Rights | $62.51 | M | 3359 | Disposed | 2026-05-09 | Common Stock (3359) | Direct |
| 2018-02-27 | Stock Appreciation Rights | $30.44 | M | 2936 | Disposed | 2025-03-02 | Common Stock (2936) | Indirect |
| 2018-02-28 | Stock Appreciation Rights | $79.58 | M | 2723 | Disposed | 2023-12-19 | Common Stock (2723) | Indirect |
| 2018-02-28 | Stock Appreciation Rights | $62.51 | M | 655 | Disposed | 2026-05-09 | Common Stock (655) | Indirect |
Footnotes
F1: The reporting person received 932 shares of common stock upon the net exercise of 15,133 stock appreciation rights ("SARs"). The reporting person forfeited 13,077 shares of common stock underlying the SARs in payment of the exercise price and 1,124 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
F2: The reporting person received 489 shares of common stock upon the net exercise of 3,359 SARs. The reporting person forfeited 2,280 shares of common stock underlying the SARs in payment of the exercise price and 590 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
F3: This transaction includes a sale of 17,493 shares pursuant to reporting persons 10b5-1 plan.
F4: This transaction was executed in multiple trades at prices ranging from $90.92 to $91.91. The price reported reflects the weighted average sale price of $91.61. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $91.92 to $92.90. The price reported reflects the weighted average sale price of $92.32. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: The reporting person received 946 shares of common stock upon the net exercise of 2,936 SARs. The reporting person forfeited 1,032 shares of common stock underlying the SARs in payment of the exercise price and 958 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
F7: The reporting person received 183 shares of common stock upon the net exercise of 2,723 SARs. The reporting person forfeited 2,353 shares of common stock underlying the SARs in payment of the exercise price and 187 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
F8: The reporting person received 104 shares of common stock upon the net exercise of 655 SARs. The reporting person forfeited 445 shares of common stock underlying the SARs in payment of the exercise price and 106 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
F9: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F10: Consists of SARs granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested May 9, 2016 and 20% will vest May 9, 2017, and the remaining 60% will vest May 9, 2018.
F11: Consists of SARs granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on each of March 2, 2016 and March 2, 2017, and the remaining 60% will vest March 2, 2018.